Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8384211 | 0.97 | PTGS2 (0.88) | PTGS2PTGS1 | |
| SCHEMBL8384084 | 0.94 | PTGS2 (1.00) | PTGS2PTGS1 | |
| SCHEMBL8386308 | 0.88 | PTGS2 (0.76) | PTGS2PTGS1 | |
| SCHEMBL8383931 | 0.86 | PTGS2 (0.74) | PTGS2PTGS1 | |
| SCHEMBL8386514 | 0.86 | PTGS2 (0.74) | PTGS2PTGS1 | |
| SCHEMBL8386299 | 0.86 | PTGS2 (0.74) | PTGS2PTGS1 | |
| SCHEMBL8386083 | 0.86 | PTGS2 (0.88) | PTGS2PTGS1 | |
| SCHEMBL8388717 | 0.86 | PTGS2 (0.74) | PTGS2PTGS1 | |
| SCHEMBL8386340 | 0.86 | PTGS2 (0.74) | PTGS2PTGS1 | |
| SCHEMBL215233 | 0.86 | PTGS2 (1.00) | PTGS2PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0743938-B1 | SUBSTITUTED SPIRO COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | SEARLE & CO (US) | 1999-04-21 | — | — | EP | claimed |
| EP-0743938-B1 | SUBSTITUTED SPIRO COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | SEARLE & CO (US) | 1999-04-21 | — | — | EP | disclosed |
| EP-0743938-A1 | SUBSTITUTED SPIRO COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1996-11-27 | — | — | EP | disclosed |
| WO-1995021817-A1 | SUBSTITUTED SPIRO COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1995-08-17 | — | — | WO | disclosed |
| US-5393790-A | Diphenyl- or phenyl/pyridyl-substituted spiroheptenes, -octenes,-nonenes or -decenes; cyclooxygenase II inhibitors; side effect reduction; antipyretics; antiarthritic agents | G.D. SEARLE & CO. (US) | 1995-02-28 | — | — | US | disclosed |